3 Strong Buy and Hold Hemp Stocks for 2021
With over 95% ballots reporting in most swing states, a Biden/Harris administration looks more likely with every passing day. While plenty of uncertainty over the legalization of marijuana in the U.S. remains, the industry for hemp-derived CBD products continues to gain momentum. Investors can capitalize on these smart hemp stock investments as many of these companies grow. Sure, many hemp stock investors see plenty of opportunity in the short term – but what are the 3 Strong Buy and Hold Hemp Stocks for 2021?
#1 Village Farms International (VFF): Largest Vertically Integrated Greenhouse Growers in North America
[stock_market_widget type=”combo” symbol=”VFF” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(0, 128, 0)”]
Village Farms International (VFF) aims to leverage its expertise as a vertically integrated greenhouse grower in the rapidly expanding cannabis space. VFF is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Its focus is to become the leading low-cost, cannabis producer in Canada.
VFF is also pursuing opportunities to gain traction in the U.S. hemp-derived CBD market and has established two joint ventures for multi-state outdoor hemp cultivation and CBD extraction.
Analysts tracking VFF stock have a 12-month average target price of $14.2. This indicates an upside potential of over 100% given its current trading price of [stock_market_widget type=”inline” symbol=”VFF” template=”basic” color=”default”]. Thus, we believe VFF is one of the 3 strong buy and hold hemp stocks for 2021.
#2 Aphria (APHA): A Diversified Hemp Stock
[stock_market_widget type=”combo” symbol=”APHA” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(0, 128, 0)”]
Aphria Inc. (APHA) is a Canadian cannabis company. It is listed on the Toronto Stock Exchange and NASDAQ, and has a market capitalization of $1.2 billion, as of January 2020, making it one of the largest cannabis companies in the world. This hemp stock offers several distinct products under six brands in the medical and adult-use categories across several unique markets. It is commendable that the company is expanding in international markets with an additional $15 million to boost its sales initiatives in Germany.
Additionally, Aphria also received the EU-GMP certification for its Malta subsidiary earlier this year which makes the expansion prospects of this company promising.
Aphria has launched various types of vape products in the market, which have garnered an encouraging response. However, it is yet to introduce derivatives of other recreational cannabis like chocolates, beverages, edibles, and more. In essence, Aphria is going strong on its medical cannabis segment and international expansion. One of the rare companies with astonishing sales growth, and strong financials, Aphria is likely to see greater heights in the next decade too.
Cannin’s analysts believe this hemp stock is one of the best buy and hold opportunities in the sector – but don’t just take our word for it. CNN’s 12-month price forecast has Aphria gaining between 12%-100% with a median expected growth of 32.3% so we believe it’s one of 3 strong buy and hold hemp stocks for 2021.
#3 GW Pharmaceuticals (GWPH): Continued Success with Critical CBD-based Pharmaceutical Drugs
[stock_market_widget type=”combo” symbol=”GWPH” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(0, 128, 0)”]
GW Pharmaceuticals (GWPH) is a British pharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country.
On November 3, GW Pharma, along with U.S. subsidiary Greenwich Biosciences, announced that it has initiated the first U.S. Phase 3 clinical trial studying nabiximols for multiple sclerosis (MS)-associated spasticity. Nabiximols is known as Sativex outside of the US and approved for use to treat MS spasticity in over 25 countries.
Positive results from three previous European Phase 3 clinical studies show nabiximols was well-tolerated and provided continued reductions in patient-reported spasticity for individuals with MS. This Phase 3 trial is one of five pivotal studies planned for nabiximols in MS spasticity, with the remaining studies on track to commence either later this year or in 2021.
GW Pharmaceuticals has a pipeline of products that are set to be launched in the near term, and it is increasingly looking like a very attractive hemp stock to buy and hold over the long term. Analysts have revised GWPH’s stock price expectations after the results and now have a 12-month target price of $184. That’s an upside of over 60% from the current price of [stock_market_widget type=”inline” symbol=”GWPH” template=”basic” color=”default”]. We believe GW Pharmaceuticals hemp stock is a strong buy and hold for 2021 and beyond.
3 Strong Buy and Hold Hemp Stocks for 2021
Cannin Investment Group: Your Hemp Stocks Experts
Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020.
Use Cannin as your resource for:
- Cannabis and hemp stocks & investing news
- Featured cannabis & hemp stocks analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in hemp stocks? No! This is the perfect time to invest.
Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.
Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.
Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best hemp stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks